ReActiv8 Stimulation Therapy Vs. Optimal Medical Management: A Randomized Controlled Trial for the Treatment of Intractable Mechanical Chronic Low Back Pain (RESTORE Trial Protocol)

Overview

Journal Pain Ther

Date 2023 Feb 14

PMID 36787013

Authors

Christopher Gilligan

Diane Burnside

Lisa Grant

R Jason Yong

Peter M Mullins

Frank Schwab

Nagy Mekhail

Affiliations

Soon will be listed here.

Abstract

Introduction: Chronic low back pain (CLBP) is the leading cause of years lived with disability globally. The role of restorative neurostimulation in the treatment of patients with refractory mechanical CLBP and multifidus muscle dysfunction has been established in one randomized controlled trial (RCT) and several clinical studies that demonstrated both safety and clinical benefit. This post-market trial provides a direct comparison to optimized medical management to test the hypothesis that the addition of restorative neurostimulation to current care paradigms results in significant improvements in back pain-related disability.

Methods And Analysis: This trial will include people who have reported significant levels of back pain and back pain-related disability with symptoms that have persisted for longer than 6 months prior to enrollment and resulted in pain on most days in the 12 months prior to enrollment. Eligible patients will be randomized to either optimal medical management or optimal medical management plus ReActiv8® restorative neurostimulation therapy. Patient-reported outcomes will be collected at regular intervals out to the 1-year primary endpoint, at which time the patients in the control arm will be offered implantation with the ReActiv8 system. Assessment of each group will continue for an additional year.

Ethics And Dissemination: The RESTORE trial follows the principles of the Declaration of Helsinki. The WCG IRB acts as the Central Institutional Review Board (IRB) for most sites and some sites will receive local IRB approval prior to enrollment of patients. Each IRB assessed the protocol and related documentation. The protocol complies with Good Clinical Practice (GCP). All patients provide written informed consent to participate in the trial.

Protocol Version: Version C, 07 Sep 2022.

Clinicaltrials: gov registration number. NCT04803214 registered March 17, 2021.

Citing Articles

Restorative Neurostimulation Therapy Compared to Optimal Medical Management: A Randomized Evaluation (RESTORE) for the Treatment of Chronic Mechanical Low Back Pain due to Multifidus Dysfunction.

Schwab F, Mekhail N, Patel K, Langhorst M, Heros R, Gentile J Pain Ther. 2025; 14(1):401-423.

PMID: 39812968 PMC: 11751280. DOI: 10.1007/s40122-024-00689-0.

References

Rubin D . Epidemiology and risk factors for spine pain. Neurol Clin. 2007; 25(2):353-71. DOI: 10.1016/j.ncl.2007.01.004. View

Woolf A, Pfleger B . Burden of major musculoskeletal conditions. Bull World Health Organ. 2004; 81(9):646-56. PMC: 2572542. View

Mehra M, Hill K, Nicholl D, Schadrack J . The burden of chronic low back pain with and without a neuropathic component: a healthcare resource use and cost analysis. J Med Econ. 2011; 15(2):245-52. DOI: 10.3111/13696998.2011.642090. View

Katz J . Lumbar disc disorders and low-back pain: socioeconomic factors and consequences. J Bone Joint Surg Am. 2006; 88 Suppl 2:21-4. DOI: 10.2106/JBJS.E.01273. View

Kapural L, Peterson E, Provenzano D, Staats P . Clinical Evidence for Spinal Cord Stimulation for Failed Back Surgery Syndrome (FBSS): Systematic Review. Spine (Phila Pa 1976). 2017; 42 Suppl 14:S61-S66. DOI: 10.1097/BRS.0000000000002213. View

Liem L, Russo M, Huygen F, Van Buyten J, Smet I, Verrills P . One-year outcomes of spinal cord stimulation of the dorsal root ganglion in the treatment of chronic neuropathic pain. Neuromodulation. 2014; 18(1):41-8. DOI: 10.1111/ner.12228. View

Chou R, Huffman L . Nonpharmacologic therapies for acute and chronic low back pain: a review of the evidence for an American Pain Society/American College of Physicians clinical practice guideline. Ann Intern Med. 2007; 147(7):492-504. DOI: 10.7326/0003-4819-147-7-200710020-00007. View

Lin D, Jones C, Compton W, Heyward J, Losby J, Murimi I . Prescription Drug Coverage for Treatment of Low Back Pain Among US Medicaid, Medicare Advantage, and Commercial Insurers. JAMA Netw Open. 2019; 1(2):e180235. PMC: 6324424. DOI: 10.1001/jamanetworkopen.2018.0235. View

Busse J, Wang L, Kamaleldin M, Craigie S, Riva J, Montoya L . Opioids for Chronic Noncancer Pain: A Systematic Review and Meta-analysis. JAMA. 2018; 320(23):2448-2460. PMC: 6583638. DOI: 10.1001/jama.2018.18472. View

10.

Deyo R, Weinstein J . Low back pain. N Engl J Med. 2001; 344(5):363-70. DOI: 10.1056/NEJM200102013440508. View

11.

Hebert J, Fritz J, Koppenhaver S, Thackeray A, Kjaer P . Predictors of clinical outcome following lumbar disc surgery: the value of historical, physical examination, and muscle function variables. Eur Spine J. 2015; 25(1):310-317. DOI: 10.1007/s00586-015-3916-z. View

12.

Deckers K, De Smedt K, Van Buyten J, Smet I, Eldabe S, Gulve A . Chronic Low Back Pain: Restoration of Dynamic Stability. Neuromodulation. 2015; 18(6):478-86. DOI: 10.1111/ner.12275. View

13.

Russo M, Deckers K, Eldabe S, Kiesel K, Gilligan C, Vieceli J . Muscle Control and Non-specific Chronic Low Back Pain. Neuromodulation. 2017; 21(1):1-9. PMC: 5814909. DOI: 10.1111/ner.12738. View

14.

Gilligan C, Volschenk W, Russo M, Green M, Gilmore C, Mehta V . An implantable restorative-neurostimulator for refractory mechanical chronic low back pain: a randomized sham-controlled clinical trial. Pain. 2021; 162(10):2486-2498. PMC: 8442741. DOI: 10.1097/j.pain.0000000000002258. View

15.

Costandi S, Kapural L, Mekhail N, Jotwani R, Bertisch S, Li S . Impact of Long-Term Evoked Compound Action Potential Controlled Closed-Loop Spinal Cord Stimulation on Sleep Quality in Patients With Chronic Pain: An EVOKE Randomized Controlled Trial Study Subanalysis. Neuromodulation. 2022; 26(5):1030-1038. DOI: 10.1016/j.neurom.2022.10.050. View

16.

Deckers K, De Smedt K, Mitchell B, Vivian D, Russo M, Georgius P . New Therapy for Refractory Chronic Mechanical Low Back Pain-Restorative Neurostimulation to Activate the Lumbar Multifidus: One Year Results of a Prospective Multicenter Clinical Trial. Neuromodulation. 2017; 21(1):48-55. PMC: 5814827. DOI: 10.1111/ner.12741. View

17.

Mitchell B, Deckers K, De Smedt K, Russo M, Georgius P, Green M . Durability of the Therapeutic Effect of Restorative Neurostimulation for Refractory Chronic Low Back Pain. Neuromodulation. 2021; 24(6):1024-1032. PMC: 8456956. DOI: 10.1111/ner.13477. View

18.

Thomson S, Chawla R, Love-Jones S, Sharma M, Vajramani G, Williams A . Restorative Neurostimulation for Chronic Mechanical Low Back Pain: Results from a Prospective Multi-centre Longitudinal Cohort. Pain Ther. 2021; 10(2):1451-1465. PMC: 8586272. DOI: 10.1007/s40122-021-00307-3. View

19.

Chan A, Tetzlaff J, Altman D, Laupacis A, Gotzsche P, Krleza-Jeric K . SPIRIT 2013 statement: defining standard protocol items for clinical trials. Ann Intern Med. 2013; 158(3):200-7. PMC: 5114123. DOI: 10.7326/0003-4819-158-3-201302050-00583. View

20.

Dowell D, Haegerich T, Chou R . CDC Guideline for Prescribing Opioids for Chronic Pain--United States, 2016. JAMA. 2016; 315(15):1624-45. PMC: 6390846. DOI: 10.1001/jama.2016.1464. View